How Many People Are Taking Mounjaro Today?

Last reviewed: July 14, 2026

Last updated: July 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide has become one of the fastest-adopted weight loss medications in recent years, with prescription fills increasing by over 300% between 2022 and 2024 across the United States. This injectable peptide activates two distinct hormone pathways that regulate appetite and blood sugar, making it a powerful option for sustained weight management. Understanding current usage trends and how to access this medication affordably can help you make an informed decision about your weight loss strategy.

Current Tirzepatide Prescription Trends Across America

Tirzepatide prescriptions have grown exponentially as healthcare providers recognize its efficacy in reducing body weight and improving metabolic health markers. Pharmacy data suggests that millions of Americans now fill tirzepatide prescriptions monthly, with demand continuing to accelerate across all age groups and regions. This surge reflects both increased clinical confidence in the medication and broader awareness among patients seeking evidence-based weight loss solutions.

The rise in tirzepatide usage has occurred alongside growing recognition of obesity as a chronic medical condition requiring long-term treatment rather than temporary intervention. Insurance coverage expansion and improved patient education have also contributed to higher adoption rates. PlexusDx has responded to this demand by offering compounded tirzepatide injection through licensed 503A pharmacies, ensuring patients can access this proven medication without waiting lists or insurance barriers.

Why Tirzepatide Adoption Rates Continue to Climb

Tirzepatide's dual-action mechanism—activating both GLP-1 and GIP receptors—delivers superior weight loss results compared to single-pathway medications in clinical trials. Patients using tirzepatide typically experience appetite suppression, reduced food cravings, and improved satiety signals that naturally support caloric deficit without restrictive dieting. These clinical advantages have made tirzepatide the preferred choice for many healthcare providers managing moderate to severe obesity.

Beyond weight loss, tirzepatide users report improvements in blood sugar control, reduced cardiovascular risk markers, and enhanced overall metabolic function. The medication's tolerability profile, when properly dosed and monitored, has also contributed to higher continuation rates among patients starting treatment. Real-world evidence from pharmacy networks shows that patients who remain on tirzepatide therapy achieve sustained weight loss of 15-22% of body weight over 12 months, driving renewed interest from both patients and clinicians.

Access to Compounded Tirzepatide Without High Prices

Traditional brand-name tirzepatide (Mounjaro and Zepbound) carries premium pricing that can exceed $1,000 per month before insurance. PlexusDx addresses this access barrier by offering compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan from licensed 503A compounding pharmacies serving all 50 states. This pricing remains flat across all dose levels—your dose may need to go up, but your price won't—making tirzepatide therapy financially sustainable for patients without insurance or those with high deductibles.

Patients choosing PlexusDx compounded tirzepatide receive medications prepared by licensed pharmacists using pharmaceutical-grade ingredients and rigorous quality standards. HSA and FSA accounts cover compounded tirzepatide, providing additional cost-saving opportunities for eligible patients. No membership fees, no insurance requirement, and no membership commitments mean that starting tirzepatide therapy is straightforward and transparent from the first injection.

Personalized Tirzepatide Therapy Through Genetic Testing

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many people are currently using tirzepatide in the United States?

Tirzepatide prescription fills have surpassed 2 million monthly in 2024, representing sustained growth since market launch. This makes tirzepatide one of the most widely used GLP-1 and GIP receptor agonists available today, with adoption continuing across all demographics and regions.

What makes tirzepatide more effective than other weight loss medications?

Tirzepatide activates two hormone receptors simultaneously—GLP-1 and GIP—whereas older medications target only one pathway. Clinical trials show tirzepatide produces 19-22% weight loss over 68 weeks, surpassing single-pathway agents and generating sustained appetite suppression and improved metabolic control.

Can I get compounded tirzepatide from PlexusDx if I don't have insurance?

Yes. PlexusDx serves all 50 states with no insurance requirement and no membership fee. Compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flat pricing, with HSA/FSA eligibility available, making it accessible regardless of insurance status.

Are compounded tirzepatide and brand-name Mounjaro the same?

PlexusDx compounded tirzepatide contains the same active pharmaceutical ingredient as brand-name products and is prepared by licensed 503A compounding pharmacies under strict quality standards. Compounding offers cost savings and accessibility without compromising medication integrity or efficacy.

How does the Precision Peptide Genetic Test improve my tirzepatide results?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.